Miozzo M, Pierotti M A, Sozzi G, Radice P, Bongarzone I, Spurr N K, Della Porta G
Division of Experimental Oncology A, Istituto Nazionale Tumori, Milan, Italy.
Oncogene. 1990 Sep;5(9):1411-4.
The chromosomal localization of TRK, a gene coding for a putative receptor molecule with an associated tyrosine kinase activity that we have found activated in 25% of patients with papillary thyroid carcinoma, was determined by Southern blot analysis of a panel of human-rodent somatic cells using a cDNA clone containing the entire human TRK proto-oncogene (Martin-Zanca et al., 1986). The TRK gene was assigned to chromosome 1. One hybrid that had retained only the short arm of the human chromosome 1 was negative. Subsequently, in situ hybridization of the same probe to human metaphase chromosomes localized the TRK gene to 1q32-q41.
我们发现,在25%的甲状腺乳头状癌患者中,TRK基因(编码一种假定的受体分子,伴有相关的酪氨酸激酶活性)被激活。通过使用包含整个人类TRK原癌基因的cDNA克隆,对一组人-啮齿类体细胞进行Southern印迹分析,确定了TRK基因的染色体定位(Martin-Zanca等人,1986年)。TRK基因被定位于1号染色体。一个仅保留了人类1号染色体短臂的杂种细胞呈阴性。随后,用同一探针与人中期染色体进行原位杂交,将TRK基因定位到1q32-q41。